BBLG Q2 2025 Earnings — Bone Biologics Corporation Revenue & Financial Results | Market Cap Arena

BBLGBone Biologics Corporation

$2M

Q2 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$748,075

Net Income

-$740,519

EPS (Diluted)

$-1.33

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$458,879

Free Cash Flow

-$458,879

Stock-Based Comp.

$72,899

Balance Sheet

Total Assets

$7M

Total Liabilities

$406,142

Stockholders' Equity

$7M

Cash & Equivalents

$7M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$748,075	-$809,665	+7.6%
Net Income	-$740,519	-$783,733	+5.5%